SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
AcelRx Pharmaceuticals to Present Top-Line Data From Phase 3 Study of Sufentanil NanoTab® PCA System vs. IV PCA Morphine at the 66th Annual PostGraduate Assembly in Anesthesiology held in New York City